![Karl Hsu](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Karl Hsu worked as Senior Vice President-Clinical Development at Acrivon Therapeutics, Inc. from 2023 to 2024.
Previously, Dr. Hsu was SVP-Clinical Research & Early Development at Zai Lab Ltd.
Anciens postes connus de Karl Hsu
| Sociétés | Poste | Fin |
|---|---|---|
| ACRIVON THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 02/01/2024 |
| ZAI LAB LIMITED | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
1
Relations au 1er degré
2
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Zai Lab Ltd.
 Zai Lab Ltd. BiotechnologyHealth Technology Develops medicine for cancer, autoimmune and infectious diseases | Health Technology |
Acrivon Therapeutics, Inc.
 Acrivon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops and sells precision oncology medicines | Health Technology |
Choisissez Zonebourse 
